cetirizine has been researched along with n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreño, C; Domènech, A; Miralpeix, M; Prats, N; Ramis, I | 1 |
1 other study(ies) available for cetirizine and n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine
| Article | Year |
|---|---|
Characterization of a model of tracheal plasma extravasation in passively sensitized rats using anti-allergic and anti-inflammatory drugs by oral and intratracheal route.
Topics: Acetates; Administration, Oral; Androstadienes; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Cell Degranulation; Cetirizine; Cromolyn Sodium; Cyclopropanes; Dinitrophenols; Fluticasone; Immunization, Passive; Indicators and Reagents; Intracellular Signaling Peptides and Proteins; Intubation, Intratracheal; Male; Mast Cells; Oxazines; Plasma; Protein-Tyrosine Kinases; Pyridines; Quinolines; Rats; Rats, Wistar; Sulfides; Syk Kinase; Trachea | 2012 |